Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › standard chemotherapy

standard chemotherapy

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of standard chemotherapy

8 trials tracked of standard chemotherapy: 3 in phase 3 or 4.

8Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 3 Phase 2 4 Other / NA 1
  1. Phase 3 PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study Completed
  2. Phase 3 A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) Completed
  3. Phase 3 A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma Completed
  4. Phase 2 A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. Completed
  5. Phase 2 A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. Completed
  6. Phase 2 Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer Completed
Show 2 more trials
  1. Phase 2 A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma. Completed
  2. N/A Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Modified Banxia Xiexin Decoction plus chemotherapy shows favorable trends in advanced colorectal cancer
Oncology RCT
Modified Banxia Xiexin Decoction plus chemotherapy shows favorable trends in advanced colorectal cancer Modified herbal decoction may extend survival time for advanced colorectal cancer patients
This randomized controlled trial in 129 patients with advanced colorectal cancer evaluated modified Banxia Xiexin Decoction (mBXD) granules …
Adding a modified herbal decoction to standard cancer treatment might extend survival time and reduce tumor growth in patients with advanced…
Apr 24, 2026